{{Rsnum
|rsid=12446319
|Chromosome=16
|position=81741193
|Orientation=plus
|GMAF=0.4954
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 48.7 | 31.9
| HCB | 45.3 | 47.4 | 7.3
| JPT | 57.5 | 39.8 | 2.7
| YRI | 9.5 | 40.8 | 49.7
| ASW | 14.0 | 45.6 | 40.4
| CHB | 45.3 | 47.4 | 7.3
| CHD | 54.1 | 41.3 | 4.6
| GIH | 42.6 | 47.5 | 9.9
| LWK | 8.3 | 38.5 | 53.2
| MEX | 12.1 | 41.4 | 46.6
| MKK | 10.3 | 44.9 | 44.9
| TSI | 24.5 | 44.1 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=9E-6
  |OR=2.03
  |ORtxt=[1.48-2.774]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}